Lovisa Österberg

411 total citations
12 papers, 301 citations indexed

About

Lovisa Österberg is a scholar working on Reproductive Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Lovisa Österberg has authored 12 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Lovisa Österberg's work include Ovarian cancer diagnosis and treatment (10 papers), Cancer Genomics and Diagnostics (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Lovisa Österberg is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Cancer Genomics and Diagnostics (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Lovisa Österberg collaborates with scholars based in Sweden and United States. Lovisa Österberg's co-authors include Kristina Levan, Karolina Partheen, György Horváth, Karin Sundfeldt, Khalil Helou, G. Horváth, Ulla Delle, Björn Olsson, Per Karlsson and Hesed Padilla‐Nash and has published in prestigious journals such as International Journal of Cancer, European Journal of Cancer and BMC Cancer.

In The Last Decade

Lovisa Österberg

12 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lovisa Österberg Sweden 11 175 121 113 72 47 12 301
Marianna Buttarelli Italy 13 179 1.0× 88 0.7× 89 0.8× 129 1.8× 41 0.9× 19 320
Shamima Yeasmin Japan 10 289 1.7× 123 1.0× 94 0.8× 115 1.6× 26 0.6× 19 442
Agnieszka Timorek Poland 9 109 0.6× 55 0.5× 122 1.1× 92 1.3× 36 0.8× 19 258
Jane Cipollone Canada 7 138 0.8× 49 0.4× 95 0.8× 95 1.3× 17 0.4× 8 284
I Schönborn Germany 6 223 1.3× 87 0.7× 102 0.9× 176 2.4× 19 0.4× 14 373
Santiago Demajo Spain 9 281 1.6× 60 0.5× 65 0.6× 99 1.4× 70 1.5× 13 450
Bożena Konopka Poland 13 319 1.8× 154 1.3× 129 1.1× 84 1.2× 51 1.1× 23 468
Iwona K. Rzepecka Poland 9 233 1.3× 87 0.7× 95 0.8× 73 1.0× 28 0.6× 14 324
Emily Rayner Netherlands 6 197 1.1× 176 1.5× 67 0.6× 144 2.0× 48 1.0× 8 441
Xiaowei Xi China 13 296 1.7× 204 1.7× 19 0.2× 82 1.1× 42 0.9× 19 419

Countries citing papers authored by Lovisa Österberg

Since Specialization
Citations

This map shows the geographic impact of Lovisa Österberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lovisa Österberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lovisa Österberg more than expected).

Fields of papers citing papers by Lovisa Österberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lovisa Österberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lovisa Österberg. The network helps show where Lovisa Österberg may publish in the future.

Co-authorship network of co-authors of Lovisa Österberg

This figure shows the co-authorship network connecting the top 25 collaborators of Lovisa Österberg. A scholar is included among the top collaborators of Lovisa Österberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lovisa Österberg. Lovisa Österberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Levan, Kristina, Karolina Partheen, Lovisa Österberg, et al.. (2010). Identification of a Gene Expression Signature for Survival Prediction in Type I Endometrial Carcinoma. Gene Expression. 14(6). 361–370. 11 indexed citations
2.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2010). Specific copy number alterations associated with docetaxel/carboplatin response in ovarian carcinomas.. PubMed. 30(11). 4451–8. 10 indexed citations
3.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2009). High-Resolution Genomic Profiling of Carboplatin Resistance in Early-Stage Epithelial Ovarian Carcinoma. Cytogenetic and Genome Research. 125(1). 8–18. 15 indexed citations
4.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2009). Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas. BMC Cancer. 9(1). 368–368. 27 indexed citations
5.
Partheen, Karolina, et al.. (2009). External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas. BMC Cancer. 9(1). 336–336. 15 indexed citations
6.
Partheen, Karolina, et al.. (2008). Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. International Journal of Cancer. 123(9). 2130–2137. 66 indexed citations
7.
Österberg, Lovisa, et al.. (2006). Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas. Cancer Genetics and Cytogenetics. 167(2). 103–108. 13 indexed citations
8.
Helou, Khalil, Hesed Padilla‐Nash, Danny Wangsa, et al.. (2006). Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors. Cancer Genetics and Cytogenetics. 170(1). 1–8. 20 indexed citations
9.
Levan, Kristina, Karolina Partheen, Lovisa Österberg, Khalil Helou, & G. Horváth. (2006). Chromosomal alterations in 98 endometrioid adenocarcinomas analyzed with comparative genomic hybridization. Cytogenetic and Genome Research. 115(1). 16–22. 20 indexed citations
10.
Partheen, Karolina, Kristina Levan, Lovisa Österberg, & György Horváth. (2006). Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors. European Journal of Cancer. 42(16). 2846–2854. 44 indexed citations
11.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, Khalil Helou, & György Horváth. (2005). Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma. Cancer Genetics and Cytogenetics. 163(2). 144–150. 25 indexed citations
12.
Partheen, Karolina, Kristina Levan, Lovisa Österberg, Khalil Helou, & György Horváth. (2004). Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage. Genes Chromosomes and Cancer. 40(4). 342–348. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianna Buttarelli Breakdown of academic impact, for papers by Shamima Yeasmin Breakdown of academic impact, for papers by Agnieszka Timorek Breakdown of academic impact, for papers by Jane Cipollone Breakdown of academic impact, for papers by I Schönborn Breakdown of academic impact, for papers by Santiago Demajo Breakdown of academic impact, for papers by Bożena Konopka Breakdown of academic impact, for papers by Iwona K. Rzepecka Breakdown of academic impact, for papers by Emily Rayner Breakdown of academic impact, for papers by Xiaowei Xi
Rankless by CCL
2026